Intense Pulsed Light Therapy for Dry Eye Disease: Analyzing Temporal Changes in Tear Film Stability and Ocular Surface between IPL Sessions.

dry eye disease evaporative dry eye intense pulsed light meibomian gland dysfunction ocular surface health tear film stability

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
30 May 2024
Historique:
received: 18 04 2024
revised: 21 05 2024
accepted: 28 05 2024
medline: 19 6 2024
pubmed: 19 6 2024
entrez: 19 6 2024
Statut: epublish

Résumé

Dry eye disease (DED), a prevalent condition with a multifactorial etiology, significantly impacts global health by causing discomfort and visual disturbance. This historical cohort study evaluates the efficacy of Intense Pulsed Light (IPL) therapy on meibomian gland dysfunction (MGD)-related evaporative DED. The study involved 110 patients (220 eyes) who underwent IPL therapy. Ethical approval was secured, and informed consent was obtained from all participants. A Tearcheck Significant improvements were observed in subjective symptoms (EFT score increased from 29.10 ± 8.87 to 35.91 ± 7.03, IPL therapy is a promising treatment for DED, improving symptoms and ocular surface health. Further research is warranted to explore long-term efficacy and optimization.

Sections du résumé

BACKGROUND BACKGROUND
Dry eye disease (DED), a prevalent condition with a multifactorial etiology, significantly impacts global health by causing discomfort and visual disturbance. This historical cohort study evaluates the efficacy of Intense Pulsed Light (IPL) therapy on meibomian gland dysfunction (MGD)-related evaporative DED.
METHODS METHODS
The study involved 110 patients (220 eyes) who underwent IPL therapy. Ethical approval was secured, and informed consent was obtained from all participants. A Tearcheck
RESULTS RESULTS
Significant improvements were observed in subjective symptoms (EFT score increased from 29.10 ± 8.87 to 35.91 ± 7.03,
CONCLUSIONS CONCLUSIONS
IPL therapy is a promising treatment for DED, improving symptoms and ocular surface health. Further research is warranted to explore long-term efficacy and optimization.

Identifiants

pubmed: 38891194
pii: healthcare12111119
doi: 10.3390/healthcare12111119
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Cristina-Patricia Pac (CP)

Department of Ophthalmology, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.

José-María Sánchez-González (JM)

Department of Physics of Condensed Matter, Optics Area, University of Seville, 41012 Seville, Spain.

Carlos Rocha-de-Lossada (C)

Department of Ophthalmology, Qvision VITHAS Almeria Hospital, 04120 Almeria, Spain.
Department of Ophthalmology, VITHAS Malaga, 29016 Malaga, Spain.
Department of Ophthalmology, Regional University Hospital of Malaga, 29009 Malaga, Spain.
Department of Surgery, University of Seville, Ophthalmology Area, 41009 Seville, Spain.

Nadina Mercea (N)

Department of Ophthalmology, Municipal Emergency Clinical Hospital, 300254 Timisoara, Romania.

Francis Ferrari (F)

Clinique Espace Nouvelle Vision, 6 Rue de la Grande Chaumière, 75006 Paris, France.

Maria Alexandra Preda (MA)

Department of Ophthalmology, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.

Cosmin Rosca (C)

Oculens Clinic, Calea Turzii no. 134-136, 400347 Cluj Napoca, Romania.

Mihnea Munteanu (M)

Department of Ophthalmology, University of Medicine and Pharmacy "Victor Babes", 300041 Timisoara, Romania.

Classifications MeSH